IDO1 INVOLVEMENT IN MEDULLOBLASTOMA: A POSSIBLE INTERACTION WITH mTOR

被引：0
|
作者：
Folgiero, Valentina [1 ]
del Bufalo, Francesca [1 ]
Carai, Andrea [1 ]
Cefalo, Maria Giuseppina [1 ]
Citti, Arianna [1 ]
Rutella, Sergio [1 ]
Locatelli, Franco [1 ]
Mastronuzzi, Angela [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Rome, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TB-023
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [31] IDO1 Is Strongly Expressed in Placental Chronic Villitis
    Bale, T. A.
    Yang, E. J.
    Jimenez, C.
    Yuan, L.
    Quade, B. J.
    MODERN PATHOLOGY, 2014, 27 : 275A - 275A
  • [32] IDO1 regulates the NLRP3 Inflammasome
    Ganoza, C.
    Dorhoi, A.
    Fae, K. C.
    Alves, P.
    Houthuys, E.
    Guhlich-Bornhof, U.
    Hurwitz, R.
    Kaufmann, S. H. E.
    IMMUNOLOGY, 2012, 137 : 6 - 6
  • [33] The ups, downs and new trends of IDO1 inhibitors
    Chen, Shulun
    Tan, Jing
    Zhang, Ao
    BIOORGANIC CHEMISTRY, 2021, 110
  • [34] IDO1 AND TARGETED IMMUNOTHERAPY IN A MOUSE GLIOBLASTOMA MODEL
    Ladomersky, Erik
    Zhai, Lijie
    Gritsina, Galina
    Lauing, Kristen
    Genet, Matthew
    Bloch, Orin
    James, C. David
    Wainwright, Derek
    NEURO-ONCOLOGY, 2016, 18 : 94 - 94
  • [35] IDO1 Is Strongly Expressed in Placental Chronic Villitis
    Bale, T. A.
    Yang, E. J.
    Jimenez, C.
    Yuan, L.
    Quade, B. J.
    LABORATORY INVESTIGATION, 2014, 94 : 275A - 275A
  • [36] Discovery of IDO1 Inhibitors: From Bench to Bedside
    Prendergast, George C.
    Malachowski, William P.
    DuHadaway, James B.
    Muller, Alexander J.
    CANCER RESEARCH, 2017, 77 (24) : 6795 - 6811
  • [37] Treatment of IDO1 and TDO2 positive tumors with a kynurenine-degrading enzyme: A highly differentiated approach from IDO1 inhibition
    Coma, Silvia
    Cavanaugh, Jillian
    Nolan, James
    Tchaicha, Jeremy
    McGovern, Karen
    Stone, Everett
    Blazeck, John
    Lamb, Candice
    Georgiou, George
    Manfredi, Mark G.
    Zhang, Michelle
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [38] Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1
    Peng, Yi-Hui
    Ueng, Shau-Hua
    Tseng, Chen-Tso
    Hung, Ming-Shiu
    Song, Jen-Shin
    Wu, Jian-Sung
    Liao, Fang-Yu
    Fan, Yu-Shiou
    Wu, Mine-Hsine
    Hsiao, Wen-Chi
    Hsueh, Ching-Cheng
    Lin, Shu-Yu
    Cheng, Chia-Yi
    Tu, Chih-Hsiang
    Lee, Lung-Chun
    Cheng, Ming-Fu
    Shia, Kak-Shan
    Shih, Chuan
    Wu, Su-Ying
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 282 - 293
  • [39] Identification and characterization of the IDO1 inhibitor LY3381916
    Dorsey, Frank C.
    Benhadji, Karim A.
    Sams, Lillian L.
    Young, Debra A.
    Schindler, John F.
    Huss, Karen L.
    Nikolayev, Alexander
    Carpenito, Carmine
    Clawson, David
    Jones, Bonita
    Faber, Andrew L.
    Thomas, James E.
    Haney, Steven A.
    Zhao, Gaiying
    McMillen, William T.
    Smeal, Tod
    Sall, Daniel J.
    Kalos, Michael D.
    Geeganage, Sandaruwan
    Henry, James R.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] Targeting the IDO1 pathway in cancer: from bench to bedside
    Ming Liu
    Xu Wang
    Lei Wang
    Xiaodong Ma
    Zhaojian Gong
    Shanshan Zhang
    Yong Li
    Journal of Hematology & Oncology, 11
12345